Quick Answer
Concord Medical Services Holdings Ltd reported Cash and Equivalents of $216.22 million for fiscal year 2024.
Concord Medical Services Holdings Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $216.22M | +271.9% |
| 2023 | $58.14M | -63.3% |
| 2022 | $158.28M | +0.6% |
| 2021 | $157.39M | -52.9% |
| 2020 | $334.26M | +349.8% |
| 2019 | $74.31M | -81.6% |
| 2018 | $404.74M | +312.2% |
| 2017 | $98.19M | -48.3% |
| 2016 | $189.91M | — |
- Concord Medical Services Holdings Ltd showed an increase of +271.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2024 period, Concord Medical Services Holdings Ltd’s cash and equivalents has grown by 13.9% (from $189.91 million to $216.22 million).
- The most recent figure is from Concord Medical Services Holdings Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: